
Loading, please wait...

Loading, please wait...

Clinicians recognize photodynamic immunotherapy for tumors as a promising treatment strategy. However, the immunosuppressive tumor microenvironment (TME) often limits its efficacy. Specifically, M2-like tumor-associated macrophages (TAMs) create a protective barrier around malignant cells. To address this, researchers developed an acid-responsive, mannose-functionalized nanoplatform called FI@PMD. M2-like macrophages selectively internalize this platform via mannose-receptor-mediated recognition. Consequently, this approach enables precise targeting within the TME.
Once the nanoplatform encounters acidic conditions, it undergoes structural dissociation. This process releases a near-infrared photosensitizer (FBC) and the Toll-like receptor 7 (TLR7) agonist imiquimod (IMQ). These components work in tandem to stimulate the immune system. Furthermore, the targeted delivery minimizes off-target effects in healthy tissues.
Upon light irradiation, the released FBC generates reactive oxygen species (ROS). These molecules trigger the polarization of TAMs from the M2 phenotype to the pro-inflammatory M1 phenotype. This transition remodels the TME and promotes an active anti-tumor response. In vivo experiments demonstrated that FI@PMD increased CD8+ cytotoxic T cell infiltration to 2.85-fold of the control group. Simultaneously, the proportion of regulatory T cells decreased. Therefore, this TAM-targeted strategy provides a powerful way to enhance photodynamic immunotherapy for tumors.
The nanoplatform features mannose functionalization, allowing it to be selectively internalized by M2-like tumor-associated macrophages through mannose-receptor-mediated recognition.
Repolarizing macrophages from the M2 to the M1 phenotype helps remodel the immunosuppressive tumor microenvironment, leading to significantly increased infiltration of cancer-killing CD8+ T cells.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new nanoplatform (FI@PMD) enhances photodynamic immunotherapy by repolarizing M2 macrophages to M1, boosting CD8+ T-cell infiltration in malignant tumors....
2 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today